HEADER GLYCOSYLTRANSFERASE 27-FEB-99 1CXL TITLE COMPLEX BETWEEN A COVALENT INTERMEDIATE AND BACILLUS CIRCULANS STRAIN TITLE 2 251 CGTASE E257Q CAVEAT 1CXL GLC B 1 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (CYCLODEXTRIN-GLYCOSYLTRANSFERASE); COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CGTASE; COMPND 5 EC: 2.4.1.19; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: COVALENTLY BOUND REACTION INTERMEDIATE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS CIRCULANS; SOURCE 3 ORGANISM_TAXID: 1397; SOURCE 4 STRAIN: 251; SOURCE 5 EXPRESSION_SYSTEM: BACILLUS SUBTILIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 1423; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: DB104A; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PDP66S; SOURCE 9 EXPRESSION_SYSTEM_GENE: CGT; SOURCE 10 OTHER_DETAILS: MUTANTS WERE CONSTRUCTED IN ECOLI STRAIN MC1061 KEYWDS GLYCOSYL HYDROLASE FAMILY 13, ALPHA-AMYLASE FAMILY, INTERMEDIATE KEYWDS 2 COMPLEX, 4- DEOXYMALTOTRIOSE, GLYCOSYLTRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.C.M.UITDEHAAG,B.W.DIJKSTRA REVDAT 5 29-JUL-20 1CXL 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 06-NOV-19 1CXL 1 JRNL REMARK LINK REVDAT 3 24-FEB-09 1CXL 1 VERSN REVDAT 2 01-APR-03 1CXL 1 JRNL REVDAT 1 03-MAY-99 1CXL 0 JRNL AUTH J.C.UITDEHAAG,R.MOSI,K.H.KALK,B.A.VAN DER VEEN,L.DIJKHUIZEN, JRNL AUTH 2 S.G.WITHERS,B.W.DIJKSTRA JRNL TITL X-RAY STRUCTURES ALONG THE REACTION PATHWAY OF CYCLODEXTRIN JRNL TITL 2 GLYCOSYLTRANSFERASE ELUCIDATE CATALYSIS IN THE ALPHA-AMYLASE JRNL TITL 3 FAMILY. JRNL REF NAT.STRUCT.BIOL. V. 6 432 1999 JRNL REFN ISSN 1072-8368 JRNL PMID 10331869 JRNL DOI 10.1038/8235 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.MOSI,H.SHAM,J.C.UITDEHAAG,R.RUITERKAMP,B.W.DIJKSTRA, REMARK 1 AUTH 2 S.G.WITHERS REMARK 1 TITL REASSESSMENT OF ACARBOSE AS A TRANSITION STATE ANALOGUE REMARK 1 TITL 2 INHIBITOR OF CYCLODEXTRIN GLYCOSYLTRANSFERASE. REMARK 1 REF BIOCHEMISTRY V. 37 17192 1998 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 9860832 REMARK 1 DOI 10.1021/BI981109A REMARK 1 REFERENCE 2 REMARK 1 AUTH B.STROKOPYTOV,R.M.KNEGTEL,D.PENNINGA,H.J.ROZEBOOM,K.H.KALK, REMARK 1 AUTH 2 L.DIJKHUIZEN,B.W.DIJKSTRA REMARK 1 TITL STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH REMARK 1 TITL 2 A MALTONONAOSE INHIBITOR AT 2.6 ANGSTROM RESOLUTION. REMARK 1 TITL 3 IMPLICATIONS FOR PRODUCT SPECIFICITY. REMARK 1 REF BIOCHEMISTRY V. 35 4241 1996 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 8672460 REMARK 1 DOI 10.1021/BI952339H REMARK 1 REFERENCE 3 REMARK 1 AUTH R.M.KNEGTEL,B.STROKOPYTOV,D.PENNINGA,O.G.FABER,H.J.ROZEBOOM, REMARK 1 AUTH 2 K.H.KALK,L.DIJKHUIZEN,B.W.DIJKSTRA REMARK 1 TITL CRYSTALLOGRAPHIC STUDIES OF THE INTERACTION OF CYCLODEXTRIN REMARK 1 TITL 2 GLYCOSYLTRANSFERASE FROM BACILLUS CIRCULANS STRAIN 251 WITH REMARK 1 TITL 3 NATURAL SUBSTRATES AND PRODUCTS. REMARK 1 REF J.BIOL.CHEM. V. 270 29256 1995 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 7493956 REMARK 1 DOI 10.1074/JBC.270.49.29256 REMARK 1 REFERENCE 4 REMARK 1 AUTH C.L.LAWSON,R.VAN MONTFORT,B.STROKOPYTOV,H.J.ROZEBOOM, REMARK 1 AUTH 2 K.H.KALK,G.E.DE VRIES,D.PENNINGA,L.DIJKHUIZEN,B.W.DIJKSTRA REMARK 1 TITL NUCLEOTIDE SEQUENCE AND X-RAY STRUCTURE OF CYCLODEXTRIN REMARK 1 TITL 2 GLYCOSYLTRANSFERASE FROM BACILLUS CIRCULANS STRAIN 251 IN A REMARK 1 TITL 3 MALTOSE-DEPENDENT CRYSTAL FORM. REMARK 1 REF J.MOL.BIOL. V. 236 590 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 8107143 REMARK 1 DOI 10.1006/JMBI.1994.1168 REMARK 2 REMARK 2 RESOLUTION. 1.81 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.81 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 3 NUMBER OF REFLECTIONS : 72330 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : RFREE REMARK 3 FREE R VALUE TEST SET SELECTION : EVERY REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.155 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3617 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5264 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 130 REMARK 3 SOLVENT ATOMS : 669 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 17.510 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.006 ; 4.000 ; 5530 REMARK 3 BOND ANGLES (DEGREES) : 1.508 ; 10.000; 7524 REMARK 3 TORSION ANGLES (DEGREES) : 16.120; 0.000 ; 3132 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.006 ; 8.000 ; 147 REMARK 3 GENERAL PLANES (A) : 0.011 ; 30.000; 795 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 1.574 ; 5.000 ; 5526 REMARK 3 NON-BONDED CONTACTS (A) : 0.012 ; 80.000; 453 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET SCALING REMARK 3 KSOL : 0.77 REMARK 3 BSOL : 216.9 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : TNT PROTGEO REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : TNT BCORREL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CXL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-MAR-99. REMARK 100 THE DEPOSITION ID IS D_1000000556. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JUL-97 REMARK 200 TEMPERATURE (KELVIN) : 100.00 REMARK 200 PH : 6.10 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8838 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 73264 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.810 REMARK 200 RESOLUTION RANGE LOW (A) : 58.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 4.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 49.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.27900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: TNT REMARK 200 STARTING MODEL: 1CXI REMARK 200 REMARK 200 REMARK: REMARK 200 ELECTRON DENSITY AT SUBSITES +1 AND +2 IS AMBIGUOUS, THREE WATER REMARK 200 MOLECULES REMARK 200 WERE PLACED THERE TO REPRESENT THIS DENSITY REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTAL SOAKED FIRST IN 4-DEOXY REMARK 280 MALTOSE,THEN IN 4-DEOXY MALTOTRIOSYL ALPHA- FLUORIDE, PH 6.10 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 58.53550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.66750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.64050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 32.66750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 58.53550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.64050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 580 CD GLU A 580 OE2 0.072 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 63 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ASP A 117 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ASP A 170 CB - CG - OD2 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASP A 282 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP A 298 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 318 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ASP A 328 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 371 CB - CG - OD2 ANGL. DEV. = -6.4 DEGREES REMARK 500 ASP A 373 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP A 458 CB - CG - OD2 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASP A 577 CB - CG - OD1 ANGL. DEV. = -6.4 DEGREES REMARK 500 ASP A 585 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 25 -70.61 -94.89 REMARK 500 ASP A 40 89.09 -151.00 REMARK 500 TRP A 101 74.65 -112.37 REMARK 500 THR A 141 -90.68 -100.69 REMARK 500 GLN A 148 69.89 -169.22 REMARK 500 ALA A 152 -136.14 50.71 REMARK 500 TYR A 195 -125.81 62.37 REMARK 500 TYR A 249 -76.04 -117.24 REMARK 500 SER A 427 41.28 -90.87 REMARK 500 ASN A 627 28.03 -158.30 REMARK 500 VAL A 629 -78.03 -76.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 CA: RESIDUES 688 AND 689 ARE CALCIUM IONS. REMARK 600 REMARK 600 GLC: THE GLC O1 ATOM IS CONNECTED TO THE C4 ATOM OF THE REMARK 600 PREVIOUS RESIDUE VIA AN ALPHA(1->4) GLYCOSIDIC BOND REMARK 600 A LOOSE O1 IS A REDUCING END WITH REMARK 600 ALPHA-ANOMERIC CONFIGURATION REMARK 600 REMARK 600 GLF IS IDENTICAL TO AN ALPHA GLUCOSE (GLC) REMARK 600 EXCEPT THAT THE O1 ATOM HAS BEEN EXCHANGED REMARK 600 BY A FLUORINE (F1) ATOM REMARK 600 REMARK 600 G4D IS IDENTICAL TO AN ALPHA GLUCOSE (GLC) REMARK 600 EXCEPT THAT ITS O4 ATOM IS ABSENT (4-DEOXY) REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 688 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 27 OD1 REMARK 620 2 ASN A 29 O 79.1 REMARK 620 3 ASN A 32 OD1 144.0 65.6 REMARK 620 4 ASN A 33 OD1 86.4 92.3 101.7 REMARK 620 5 GLY A 51 O 75.9 153.4 136.7 95.2 REMARK 620 6 ASP A 53 OD2 81.5 79.0 84.5 166.2 88.3 REMARK 620 7 HOH A 969 O 143.4 135.2 72.5 80.7 71.3 113.0 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 689 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 139 OD1 REMARK 620 2 ILE A 190 O 153.6 REMARK 620 3 ASP A 199 OD1 78.0 118.0 REMARK 620 4 ASP A 199 OD2 126.2 78.1 53.0 REMARK 620 5 HIS A 233 O 75.0 80.2 141.0 158.2 REMARK 620 6 HOH A 941 O 68.7 132.9 76.4 78.5 117.9 REMARK 620 7 HOH A 959 O 94.0 73.4 72.3 91.2 81.8 146.9 REMARK 620 8 HOH A1004 O 117.7 67.0 135.7 89.8 82.4 72.8 139.3 REMARK 620 N 1 2 3 4 5 6 7 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE CONTAINING MUTANT E257Q REMARK 800 REMARK 800 SITE_IDENTIFIER: CA1 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: FIRST CALCIUM BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: CA2 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: SECOND CALCIUM BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: 16 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: FIRST MALTOSE BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: 26 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: SECOND MALTOSE BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: 36 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: THIRD MALTOSE BINDING SITE. THIS SITE ALSO REMARK 800 INCLUDES RESIDUES SER 537, ALA 539, AND ASP 540 FROM A SYMMETRY- REMARK 800 RELATED MOLECULE. REMARK 999 REMARK 999 SEQUENCE REMARK 999 SER 400 AFTER REINTERPRETATION OF SEQUENCE DATA. DBREF 1CXL A 1 686 UNP P43379 CDGU_BACCI 28 713 SEQADV 1CXL GLN A 257 UNP P43379 GLU 284 ENGINEERED SEQADV 1CXL SER A 400 UNP P43379 CYS 400 SEE REMARK 999 SEQRES 1 A 686 ALA PRO ASP THR SER VAL SER ASN LYS GLN ASN PHE SER SEQRES 2 A 686 THR ASP VAL ILE TYR GLN ILE PHE THR ASP ARG PHE SER SEQRES 3 A 686 ASP GLY ASN PRO ALA ASN ASN PRO THR GLY ALA ALA PHE SEQRES 4 A 686 ASP GLY THR CYS THR ASN LEU ARG LEU TYR CYS GLY GLY SEQRES 5 A 686 ASP TRP GLN GLY ILE ILE ASN LYS ILE ASN ASP GLY TYR SEQRES 6 A 686 LEU THR GLY MET GLY VAL THR ALA ILE TRP ILE SER GLN SEQRES 7 A 686 PRO VAL GLU ASN ILE TYR SER ILE ILE ASN TYR SER GLY SEQRES 8 A 686 VAL ASN ASN THR ALA TYR HIS GLY TYR TRP ALA ARG ASP SEQRES 9 A 686 PHE LYS LYS THR ASN PRO ALA TYR GLY THR ILE ALA ASP SEQRES 10 A 686 PHE GLN ASN LEU ILE ALA ALA ALA HIS ALA LYS ASN ILE SEQRES 11 A 686 LYS VAL ILE ILE ASP PHE ALA PRO ASN HIS THR SER PRO SEQRES 12 A 686 ALA SER SER ASP GLN PRO SER PHE ALA GLU ASN GLY ARG SEQRES 13 A 686 LEU TYR ASP ASN GLY THR LEU LEU GLY GLY TYR THR ASN SEQRES 14 A 686 ASP THR GLN ASN LEU PHE HIS HIS ASN GLY GLY THR ASP SEQRES 15 A 686 PHE SER THR THR GLU ASN GLY ILE TYR LYS ASN LEU TYR SEQRES 16 A 686 ASP LEU ALA ASP LEU ASN HIS ASN ASN SER THR VAL ASP SEQRES 17 A 686 VAL TYR LEU LYS ASP ALA ILE LYS MET TRP LEU ASP LEU SEQRES 18 A 686 GLY ILE ASP GLY ILE ARG MET ASP ALA VAL LYS HIS MET SEQRES 19 A 686 PRO PHE GLY TRP GLN LYS SER PHE MET ALA ALA VAL ASN SEQRES 20 A 686 ASN TYR LYS PRO VAL PHE THR PHE GLY GLN TRP PHE LEU SEQRES 21 A 686 GLY VAL ASN GLU VAL SER PRO GLU ASN HIS LYS PHE ALA SEQRES 22 A 686 ASN GLU SER GLY MET SER LEU LEU ASP PHE ARG PHE ALA SEQRES 23 A 686 GLN LYS VAL ARG GLN VAL PHE ARG ASP ASN THR ASP ASN SEQRES 24 A 686 MET TYR GLY LEU LYS ALA MET LEU GLU GLY SER ALA ALA SEQRES 25 A 686 ASP TYR ALA GLN VAL ASP ASP GLN VAL THR PHE ILE ASP SEQRES 26 A 686 ASN HIS ASP MET GLU ARG PHE HIS ALA SER ASN ALA ASN SEQRES 27 A 686 ARG ARG LYS LEU GLU GLN ALA LEU ALA PHE THR LEU THR SEQRES 28 A 686 SER ARG GLY VAL PRO ALA ILE TYR TYR GLY THR GLU GLN SEQRES 29 A 686 TYR MET SER GLY GLY THR ASP PRO ASP ASN ARG ALA ARG SEQRES 30 A 686 ILE PRO SER PHE SER THR SER THR THR ALA TYR GLN VAL SEQRES 31 A 686 ILE GLN LYS LEU ALA PRO LEU ARG LYS SER ASN PRO ALA SEQRES 32 A 686 ILE ALA TYR GLY SER THR GLN GLU ARG TRP ILE ASN ASN SEQRES 33 A 686 ASP VAL LEU ILE TYR GLU ARG LYS PHE GLY SER ASN VAL SEQRES 34 A 686 ALA VAL VAL ALA VAL ASN ARG ASN LEU ASN ALA PRO ALA SEQRES 35 A 686 SER ILE SER GLY LEU VAL THR SER LEU PRO GLN GLY SER SEQRES 36 A 686 TYR ASN ASP VAL LEU GLY GLY LEU LEU ASN GLY ASN THR SEQRES 37 A 686 LEU SER VAL GLY SER GLY GLY ALA ALA SER ASN PHE THR SEQRES 38 A 686 LEU ALA ALA GLY GLY THR ALA VAL TRP GLN TYR THR ALA SEQRES 39 A 686 ALA THR ALA THR PRO THR ILE GLY HIS VAL GLY PRO MET SEQRES 40 A 686 MET ALA LYS PRO GLY VAL THR ILE THR ILE ASP GLY ARG SEQRES 41 A 686 GLY PHE GLY SER SER LYS GLY THR VAL TYR PHE GLY THR SEQRES 42 A 686 THR ALA VAL SER GLY ALA ASP ILE THR SER TRP GLU ASP SEQRES 43 A 686 THR GLN ILE LYS VAL LYS ILE PRO ALA VAL ALA GLY GLY SEQRES 44 A 686 ASN TYR ASN ILE LYS VAL ALA ASN ALA ALA GLY THR ALA SEQRES 45 A 686 SER ASN VAL TYR ASP ASN PHE GLU VAL LEU SER GLY ASP SEQRES 46 A 686 GLN VAL SER VAL ARG PHE VAL VAL ASN ASN ALA THR THR SEQRES 47 A 686 ALA LEU GLY GLN ASN VAL TYR LEU THR GLY SER VAL SER SEQRES 48 A 686 GLU LEU GLY ASN TRP ASP PRO ALA LYS ALA ILE GLY PRO SEQRES 49 A 686 MET TYR ASN GLN VAL VAL TYR GLN TYR PRO ASN TRP TYR SEQRES 50 A 686 TYR ASP VAL SER VAL PRO ALA GLY LYS THR ILE GLU PHE SEQRES 51 A 686 LYS PHE LEU LYS LYS GLN GLY SER THR VAL THR TRP GLU SEQRES 52 A 686 GLY GLY SER ASN HIS THR PHE THR ALA PRO SER SER GLY SEQRES 53 A 686 THR ALA THR ILE ASN VAL ASN TRP GLN PRO HET GLC B 1 11 HET GLC B 2 11 HET G4D B 3 10 HET GLC C 1 12 HET G4D C 2 10 HET GLF D 1 12 HET GLC D 2 11 HET G4D D 3 10 HET GLF E 1 12 HET GLC E 2 11 HET G4D E 3 10 HET CA A 688 1 HET CA A 689 1 HET MPD A 701 8 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM G4D 4-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM GLF ALPHA-D-GLUCOPYRANOSYL FLUORIDE HETNAM CA CALCIUM ION HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL FORMUL 2 GLC 5(C6 H12 O6) FORMUL 2 G4D 4(C6 H12 O5) FORMUL 4 GLF 2(C6 H11 F O5) FORMUL 6 CA 2(CA 2+) FORMUL 8 MPD C6 H14 O2 FORMUL 9 HOH *669(H2 O) HELIX 1 1 THR A 22 ARG A 24 5 3 HELIX 2 2 PRO A 30 ASN A 32 5 3 HELIX 3 3 GLY A 36 ALA A 38 5 3 HELIX 4 4 TRP A 54 ASN A 62 1 9 HELIX 5 5 THR A 67 MET A 69 5 3 HELIX 6 6 ILE A 115 LYS A 128 1 14 HELIX 7 7 THR A 186 TYR A 191 1 6 HELIX 8 8 SER A 205 ASP A 220 1 16 HELIX 9 9 VAL A 231 HIS A 233 5 3 HELIX 10 10 PHE A 236 LYS A 250 1 15 HELIX 11 11 PRO A 267 GLU A 275 1 9 HELIX 12 12 PHE A 283 PHE A 293 1 11 HELIX 13 13 MET A 300 ASP A 313 1 14 HELIX 14 14 VAL A 317 ASP A 319 5 3 HELIX 15 15 ARG A 339 THR A 351 1 13 HELIX 16 16 THR A 362 GLN A 364 5 3 HELIX 17 17 THR A 386 SER A 400 1 15 HELIX 18 18 PRO A 402 TYR A 406 1 5 HELIX 19 19 SER A 473 GLY A 475 5 3 HELIX 20 20 GLY A 538 ASP A 540 5 3 HELIX 21 21 SER A 611 LEU A 613 5 3 HELIX 22 22 PRO A 618 LYS A 620 5 3 SHEET 1 A 6 PRO A 356 TYR A 359 0 SHEET 2 A 6 VAL A 16 ILE A 20 1 N ILE A 17 O PRO A 356 SHEET 3 A 6 ALA A 73 ILE A 76 1 N ALA A 73 O TYR A 18 SHEET 4 A 6 LYS A 131 PHE A 136 1 N LYS A 131 O ILE A 74 SHEET 5 A 6 GLY A 225 MET A 228 1 N GLY A 225 O ILE A 134 SHEET 6 A 6 PHE A 253 GLY A 256 1 N PHE A 253 O ILE A 226 SHEET 1 B 2 ILE A 87 TYR A 89 0 SHEET 2 B 2 VAL A 92 ASN A 94 -1 N ASN A 94 O ILE A 87 SHEET 1 C 4 THR A 487 THR A 493 0 SHEET 2 C 4 ASN A 428 ASN A 435 -1 N ALA A 433 O ALA A 488 SHEET 3 C 4 VAL A 418 PHE A 425 -1 N PHE A 425 O ASN A 428 SHEET 4 C 4 SER A 408 ILE A 414 -1 N TRP A 413 O ILE A 420 SHEET 1 D 2 ALA A 442 ILE A 444 0 SHEET 2 D 2 PHE A 480 LEU A 482 -1 N LEU A 482 O ALA A 442 SHEET 1 E 2 GLY A 454 TYR A 456 0 SHEET 2 E 2 LEU A 469 VAL A 471 -1 N VAL A 471 O GLY A 454 SHEET 1 F 3 MET A 508 LYS A 510 0 SHEET 2 F 3 PHE A 579 LEU A 582 1 N GLU A 580 O ALA A 509 SHEET 3 F 3 GLY A 559 TYR A 561 -1 N TYR A 561 O PHE A 579 SHEET 1 G 4 THR A 500 GLY A 505 0 SHEET 2 G 4 THR A 514 ARG A 520 -1 N ARG A 520 O THR A 500 SHEET 3 G 4 GLN A 548 LYS A 552 -1 N VAL A 551 O ILE A 515 SHEET 4 G 4 ILE A 541 GLU A 545 -1 N GLU A 545 O GLN A 548 SHEET 1 H 3 THR A 534 SER A 537 0 SHEET 2 H 3 THR A 528 PHE A 531 -1 N PHE A 531 O THR A 534 SHEET 3 H 3 ILE A 563 ALA A 566 -1 N ALA A 566 O THR A 528 SHEET 1 I 3 TRP A 636 PRO A 643 0 SHEET 2 I 3 GLN A 586 ASN A 594 -1 N VAL A 593 O TRP A 636 SHEET 3 I 3 ALA A 678 ASN A 683 1 N ALA A 678 O ARG A 590 SHEET 1 J 3 ASN A 603 GLY A 608 0 SHEET 2 J 3 THR A 647 LYS A 655 -1 N LYS A 655 O ASN A 603 SHEET 3 J 3 HIS A 668 THR A 671 -1 N PHE A 670 O ILE A 648 SHEET 1 K 2 LEU A 653 GLN A 656 0 SHEET 2 K 2 THR A 659 TRP A 662 -1 N THR A 661 O LYS A 654 SHEET 1 L 2 LEU A 157 ASP A 159 0 SHEET 2 L 2 THR A 162 GLY A 165 -1 N GLY A 165 O LEU A 157 SSBOND 1 CYS A 43 CYS A 50 1555 1555 2.04 LINK OD2 ASP A 229 C1 GLC B 1 1555 1555 1.47 LINK O4 GLC B 1 C1 GLC B 2 1555 1555 1.41 LINK O4 GLC B 2 C1 G4D B 3 1555 1555 1.42 LINK O4 GLC C 1 C1 G4D C 2 1555 1555 1.41 LINK O4 GLF D 1 C1 GLC D 2 1555 1555 1.41 LINK O4 GLC D 2 C1 G4D D 3 1555 1555 1.41 LINK O4 GLF E 1 C1 GLC E 2 1555 1555 1.41 LINK O4 GLC E 2 C1 G4D E 3 1555 1555 1.41 LINK OD1 ASP A 27 CA CA A 688 1555 1555 2.32 LINK O ASN A 29 CA CA A 688 1555 1555 2.50 LINK OD1 ASN A 32 CA CA A 688 1555 1555 2.48 LINK OD1 ASN A 33 CA CA A 688 1555 1555 2.26 LINK O GLY A 51 CA CA A 688 1555 1555 2.47 LINK OD2 ASP A 53 CA CA A 688 1555 1555 2.31 LINK OD1 ASN A 139 CA CA A 689 1555 1555 2.40 LINK O ILE A 190 CA CA A 689 1555 1555 2.51 LINK OD1 ASP A 199 CA CA A 689 1555 1555 2.52 LINK OD2 ASP A 199 CA CA A 689 1555 1555 2.50 LINK O HIS A 233 CA CA A 689 1555 1555 2.41 LINK CA CA A 688 O HOH A 969 1555 1555 2.48 LINK CA CA A 689 O HOH A 941 1555 1555 2.42 LINK CA CA A 689 O HOH A 959 1555 1555 2.36 LINK CA CA A 689 O HOH A1004 1555 1555 2.34 CISPEP 1 ASP A 371 PRO A 372 0 5.45 CISPEP 2 GLY A 505 PRO A 506 0 -3.37 CISPEP 3 GLY A 623 PRO A 624 0 1.30 CISPEP 4 TYR A 633 PRO A 634 0 5.12 SITE 1 CAT 3 ASP A 229 GLN A 257 ASP A 328 SITE 1 CA1 6 ASP A 27 ASN A 29 ASN A 32 ASN A 33 SITE 2 CA1 6 GLY A 51 ASP A 53 SITE 1 CA2 4 ASN A 139 ILE A 190 ASP A 199 HIS A 233 SITE 1 16 6 SER A 382 TRP A 616 LYS A 651 TRP A 662 SITE 2 16 6 GLU A 663 ASN A 667 SITE 1 26 7 THR A 598 ALA A 599 GLY A 601 ASN A 603 SITE 2 26 7 ASN A 627 GLN A 628 TYR A 633 SITE 1 36 7 TYR A 301 GLU A 411 ARG A 412 TRP A 413 SITE 2 36 7 ILE A 414 GLY A 446 VAL A 448 CRYST1 117.071 109.281 65.335 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008542 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009151 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015306 0.00000 MASTER 368 0 14 22 36 0 10 6 0 0 0 53 END